Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma

Clinical trial NCT04712864 · UNKNOWN

Trial details

NCT number: NCT04712864
Sponsor: Legend Biotech USA Inc
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

T-Cell Lymphoma Peripheral T-Cell Lymphoma Refractory Cutaneous T-Cell Lymphoma Refractory Cutaneous T-Cell Lymphoma Recurrent Peripheral T-Cell Lymphoma Recurrent

Start date: 2021-09-13
Primary completion: 2023-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.